Clin Exp Otorhinolaryngol.  2010 Jun;3(2):84-90. 10.3342/ceo.2010.3.2.84.

Transplantation of Neural Stem Cells in Anosmic Mice

Affiliations
  • 1Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
  • 2Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. kimemail@snubh.org
  • 3Sensory Organ Research Institute, Medical Research Center, Seoul, Korea.

Abstract


OBJECTIVES
Treating olfactory dysfunction is a challenge for physicians. One of the therapeutic options could be transplantation of stem cells. In this study, neural stem cells were transplanted into anosmic mice.
METHODS
Neural stem cells were generated from the olfactory bulb of green fluorescent protein (GFP)-transgenic C57BL6 mice. Anosmia were induced by injection of intraperitoneal 3-methylindole. The neural stem cells were transplanted transnasally on the next day. The olfactory function was evaluated by a food-finding test once a week. The olfactory neuroepithelium was harvested for histologic examination and protein analysis at 4 weeks.
RESULTS
Twenty-five percent (6/24) of the control mice that were not transplanted with neural stem cells survived at 4 weeks while 67% (8/12) of the transplanted mice survived (P=0.029). The food finding test showed that the transplanted mice resumed finding food at 3 weeks while the control mice resumed finding food at 4 weeks. GFP-positive cells were observed in the olfactory neuroepithelium of the transplanted mice. Western blotting revealed that the olfactory marker protein expression was significantly lower in the control mice than that in the transplanted mice.
CONCLUSION
This study demonstrated that improvement of mouse survival was achieved and recovery of olfactory function was promoted by transnasal transplantation of neural stem cells in the anosmic mouse model. These results indicate that stem cells might be one of the future modalities for treating olfactory impairment.

Keyword

Neural stem cell; Anosmia; Transplantation; Smell

MeSH Terms

Animals
Blotting, Western
Mice
Neural Stem Cells
Olfaction Disorders
Olfactory Bulb
Olfactory Marker Protein
Skatole
Smell
Stem Cells
Transplants
Olfactory Marker Protein
Skatole

Reference

1. Lin SH, Chu ST, Yuan BC, Shu CH. Survey of the frequency of olfactory dysfunction in Taiwan. J Chin Med Assoc. 2009; 2. 72(2):68–71. PMID: 19251533.
Article
2. Doty RL. The olfactory system and its disorders. Semin Neurol. 2009; 2. 29(1):74–81. PMID: 19214935.
Article
3. Buck L, Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell. 1991; 4. 65(1):175–187. PMID: 1840504.
Article
4. Nordin S, Bramerson A. Complaints of olfactory disorders: epidemiology, assessment and clinical implications. Curr Opin Allergy Clin Immunol. 2008; 2. 8(1):10–15. PMID: 18188011.
Article
5. Beites CL, Kawauchi S, Crocker CE, Calof AL. Identification and molecular regulation of neural stem cells in the olfactory epithelium. Exp Cell Res. 2005; 6. 306(2):309–316. PMID: 15925585.
Article
6. Iwai N, Zhou Z, Roop DR, Behringer RR. Horizontal basal cells are multipotent progenitors in normal and injured adult olfactory epithelium. Stem Cells. 2008; 5. 26(5):1298–1306. PMID: 18308944.
Article
7. Dimmeler S, Zeiher AM. Cell therapy of acute myocardial infarction: open questions. Cardiology. 2009; 113(3):155–160. PMID: 19122455.
Article
8. Andres RH, Choi R, Steinberg GK, Guzman R. Potential of adult neural stem cells in stroke therapy. Regen Med. 2008; 11. 3(6):893–905. PMID: 18947311.
9. Ahn JM, Lee CH, Kim DY, Rhee CS, Min YG, Kim JW. Maintenance of regional difference in cellular composition of neurospheres derived from adult mouse olfactory bulb. Eur Arch Otorhinolaryngol. 2008; 4. 265(4):429–434. PMID: 17938947.
Article
10. Kim SU, de Vellis J. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res. 2009; 8. 87(10):2183–2200. PMID: 19301431.
Article
11. Madhavan L, Daley BF, Paumier KL, Collier TJ. Transplantation of subventricular zone neural precursors induces an endogenous precursor cell response in a rat model of Parkinson's disease. J Comp Neurol. 2009; 7. 515(1):102–115. PMID: 19399899.
Article
12. Greene P. Cell-based therapies in Parkinson's disease. Curr Neurol Neurosci Rep. 2009; 7. 9(4):292–297. PMID: 19515281.
Article
13. Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci. 2009; 5. 30(5):260–267. PMID: 19362379.
Article
14. Xuan AG, Luo M, Ji WD, Jin WD, Long DH. Effects of engrafted neural stem cells in Alzheimer's disease rats. Neurosci Lett. 2009; 1. 450(2):167–171. PMID: 19070649.
Article
15. Mimeault M, Batra SK. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev. 2008; Spring. 4(1):27–49. PMID: 18288619.
Article
16. Franceschini V, Bettini S, Pifferi S, Rosellini A, Menini A, Saccardi R, et al. Human cord blood CD133+ stem cells transplanted to nodscid mice provide conditions for regeneration of olfactory neuroepithelium after permanent damage induced by dichlobenil. Stem Cells. 2009; 4. 27(4):825–835. PMID: 19350683.
Article
17. Kim YM, Choi YS, Choi JW, Park YH, Koo BS, Roh HJ, et al. Effects of systemic transplantation of adipose tissue-derived stem cells on olfactory epithelium regeneration. Laryngoscope. 2009; 5. 119(5):993–999. PMID: 19296495.
Article
18. Tsujigiwa H, Nishizaki K, Teshima T, Takeda Y, Yoshinobu J, Takeuchi A, et al. The engraftment of transplanted bone marrow-derived cells into the olfactory epithelium. Brain Res. 2005; 8. 1052(1):10–15. PMID: 15996641.
Article
19. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009; 6. 18(5):683–692. PMID: 19099374.
Article
20. Smart N, Riley PR. The stem cell movement. Circ Res. 2008; 5. 102(10):1155–1168. PMID: 18497316.
Article
Full Text Links
  • CEO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr